{"transactions":[{"id":1182851,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81211,"kind":"person","name":"Velden Claus Vander","position":1,"cik":"0001733908","reported_name":"Velden Claus Vander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T01:45:23.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on March 31, 2026"}],"balance_after":50000,"derivative":{"exercise_price":8.58,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-25-000514","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112225000514/ownership.xml","form_type":"4"}},{"id":1622130,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81211,"kind":"person","name":"Velden Claus Vander","position":1,"cik":"0001733908","reported_name":"Velden Claus Vander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-23T11:04:31.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in equal installments over three years from the grant date."}],"balance_after":50000,"derivative":{"exercise_price":5.36,"exercise_date":"2025-02-20","expiration_date":"2034-02-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-24-000296","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112224000296/ownership.xml","form_type":"4"}},{"id":1927247,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81211,"kind":"person","name":"Velden Claus Vander","position":1,"cik":"0001733908","reported_name":"Velden Claus Vander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T21:31:06.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in equal instalments over three years from the grant date"}],"balance_after":50000,"derivative":{"exercise_price":8.57,"exercise_date":"2024-03-31","expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-23-000583","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112223000583/ownership.xml","form_type":"4"}},{"id":2219258,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81211,"kind":"person","name":"Velden Claus Vander","position":1,"cik":"0001733908","reported_name":"Velden Claus Vander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T21:23:31.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":10.09,"exercise_date":"2023-06-27","expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-22-001150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112222001150/ownership.xml","form_type":"4"}},{"id":2614488,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81211,"kind":"person","name":"Velden Claus Vander","position":1,"cik":"0001733908","reported_name":"Velden Claus Vander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-04T21:38:51.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":18.11,"exercise_date":"2022-08-02","expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001731122-21-001304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221001304/ownership.xml","form_type":"4"}},{"id":2925163,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81211,"kind":"person","name":"Velden Claus Vander","position":1,"cik":"0001733908","reported_name":"Velden Claus Vander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-04T19:20:20.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":5.49,"exercise_date":"2021-12-30","expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001731122-21-000006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000006/ownership.xml","form_type":"4"}},{"id":3315150,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81211,"kind":"person","name":"Velden Claus Vander","position":1,"cik":"0001733908","reported_name":"Velden Claus Vander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-08T23:00:27.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":2.96,"exercise_date":"2021-01-06","expiration_date":"2030-01-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-20-000023","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112220000023/ownership.xml","form_type":"4"}},{"id":3798141,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81211,"kind":"person","name":"Velden Claus Vander","position":1,"cik":"0001733908","reported_name":"Velden Claus Vander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-03T21:32:45.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":45500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest upon the achievement of 50% enrollment in the Company's Alzheimer's disease and Parkinson's disease dementia clinical trials."}],"balance_after":45500,"derivative":{"exercise_price":2.58,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":45500},"source":{"system":"sec-edgar","filing":"0001615774-18-010445","document":"s113107_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000161577418010445/s113107_form4.xml","form_type":"4"}}]}